A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Summary The Mixed Lineage Leukemia gene (MLL) is altered in leukemia by chromosomal translocations to produce oncoproteins comprised of the MLL N-terminus fused to the C-terminus of a partner protein. Here, we used domain-focused CRISPR screening to identify ZFP64 as an essential transcription factor in MLL-rearranged leukemia. We show that the critical function of ZFP64 in leukemia is to maintain MLL expression via binding to the MLL promoter, which is the most enriched location of ZFP64 occupancy in the human genome. The specificity of ZFP64 for MLL is accounted for by an exceptional density of ZFP64 motifs embedded within the MLL promoter. These findings demonstrate how a sequence anomaly of an oncogene promoter can impose a transcriptional addiction in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FIMO: scanning for occurrences of a given motif
Grant, C. E., Bailey, T. L., & Noble, W. S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr064 · Cited by 4,247
Differential analysis of gene regulation at transcript resolution with RNA-seq
Trapnell, C., Hendrickson, D. G., Sauvageau, M., Goff, L., Rinn, J. L., & Pachter, L. (2013) · Nature Biotechnology · doi:10.1038/nbt.2450 · Cited by 3,492 · cited 1×
“Mapped reads were then analyzed using Cuffdiff (Trapnell et al., 2013) identifying differentially expressed coding genes, while structural RNAs were masked.”
MethodDiscovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · cited 1×
“Cancer genes identified by (Lawrence et al., 2014) (n=260) were then investigated for exceptional motif count enrichment using a ranked promoter motif count list for each motif in the JASPAR database.”
MethodSelective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961 · cited 1×
“Super-enhancers are one proposed mechanism underlying this phenomenon, in which clusters of enhancers with exceptional enrichment of transcriptional cofactors render nearby cancer genes hypersensitive to perturbation (Loven et al., 2013).”
BackgroundSelf-citationGenome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 2×
“pyogenes Cas9 linked to transcriptional activation domains, which allows for sgRNA-directed transcriptional activation of endogenous promoter regions (Konermann et al., 2015) (Figure S5A–B).”
BackgroundMethodTranscription factors: from enhancer binding to developmental control
Spitz, F., & Furlong, E. E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3207 · Cited by 2,227 · cited 1×
“A prevailing model of cis-element architecture at promoters and enhancers is the presence of diverse motifs within a short sequence interval, which enable cooperative functions among different TFs to specify a transcriptional state (Long et al., 2016; Spitz and Furlong, 2012).”
BackgroundIdentification and characterization of essential genes in the human genome
Wang, T., Birsoy, K., Hughes, N. W., Krupczak, K. M., Post, Y., Wei, J. J., Lander, E. S., & Sabatini, D. M. (2015) · Science · doi:10.1126/science.aac7041 · Cited by 1,617 · cited 2×
“Average log2 fold change in abundance of all sgRNA against a given domain were calculated, as described previously (Wang et al., 2015b).”
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513 · cited 1×
“The key target genes of MLL fusion proteins include HOXA9, MEIS1, and MEF2C, which encode leukemogenic transcription factors (Armstrong et al., 2002; Krivtsov et al., 2006).”
BackgroundEver-Changing Landscapes: Transcriptional Enhancers in Development and Evolution
Long, H. K., Prescott, S. L., & Wysocka, J. (2016) · Cell · doi:10.1016/j.cell.2016.09.018 · Cited by 945 · cited 1×
“A prevailing model of cis-element architecture at promoters and enhancers is the presence of diverse motifs within a short sequence interval, which enable cooperative functions among different TFs to specify a transcriptional state (Long et al., 2016; Spitz and Furlong, 2012).”
BackgroundWunderlich, M., Chou, F.-S., Link, K. A., Mizukawa, B., Perry, R. L., Carroll, M., & Mulloy, J. C. (2010) · Leukemia · doi:10.1038/leu.2010.158 · Cited by 415 · cited 1×
“We obtained AML lines derived by transducing human cord blood derived CD34+ hematopoietic cells with retroviral vectors that expression MLL-AF9/NrasG12D or MLL-AF9/FLT3ITD cDNAs via a the LTR promoter and performed CRISPR-based targeting of ZFP64 (Wunderlich et al., 2010; Wunderlich et al., 2013).”
MethodMathas, S., Hinz, M., Anagnostopoulos, I., Krappmann, D., Lietz, A., Jundt, F., Bommert, K., Mechta‐Grigoriou, F., Stein, H., Dörken, B., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf389 · Cited by 375
Gotea, V., Visel, A., Westlund, J. M., Nobrega, M. A., Pennacchio, L. A., & Ovcharenko, I. (2010) · Genome Research · doi:10.1101/gr.104471.109 · Cited by 248 · cited 2×
“Since homotypic motif clusters are present at a significant fraction of cis-regulatory elements in the human genome (Gotea et al., 2010), this mechanism may have a broader significance as a source of transcriptional vulnerabilities in cancer and in other diseases.”
BackgroundResultWang, E., Kawaoka, S., Roe, J.-S., Shi, J., Hohmann, A. F., Xu, Y., Bhagwat, A. S., Suzuki, Y., Kinney, J. B., & Vakoc, C. R. (2015) · eLife · doi:10.7554/elife.06377 · Cited by 54 · cited 2×
“1 motifs, which are triggers for outlier levels of TRIM33 recruitment to cause repression of neighboring genes Bim and Atp1b3 (Wang et al., 2015a).”
BackgroundSelf-citationPU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway
Zhou, J., Wu, J., Li, B., Liu, D., Yu, J., Yan, X., Zheng, S., Wang, J., Zhang, L., Zhang, L., et al. (2014) · Leukemia · doi:10.1038/leu.2013.384 · Cited by 53 · cited 1×
“While CEBPA, GFI1, and SPI1 are known to play a role in MLL fusion leukemia (MaiquesDiaz et al., 2018; Ohlsson et al., 2014; Ye et al., 2015; Zhou et al., 2014), ZFP64 has not been previously studied in this disease.”
BackgroundSelf-citation
Cited by
JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles
Castro-Mondragon, J. A., Riudavets-Puig, R., Rauluseviciute, I., Berhanu Lemma, R., Turchi, L., Blanc-Mathieu, R., Lucas, J., Boddie, P., Khan, A., Manosalva Pérez, N., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1113 · Cited by 1,935
“A potential contributing challenge to obtaining orthogonal evidence may be the fact that many zinc-fingers, which represent the largest class of TFs, have been reported to regulate a limited number or even a single gene (e.g. Zfp568 (64), ZNF558 (65), ZNF410 (66) and ZFP64 (67)).”
A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia
(2022) · doi:10.1101/gad.349284.121 · Cited by 31
A microglia clonal inflammatory disorder in Alzheimer’s disease
Vicario, R., Fragkogianni, S., Weber, L., Lazarov, T., Hu, Y., Hayashi, S. Y., Craddock, B., Socci, N. D., Alberdi, A., Baako, A., et al. (2025) · eLife · doi:10.7554/elife.96519.3 · Cited by 21
Metadata
- Authors
- Lu, B., Klingbeil, O., Tarumoto, Y., Somerville, T. D. D., Huang, Y.-H., Wei, Y., Wai, D. C., Low, J. K. K., Milazzo, J. P., Wu, X. S., Cao, Z., Yan, X., Demerdash, O. E., Huang, G., Mackay, J. P., Kinney, J. B., Shi, J., & Vakoc, C. R.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 34
- Issue
- 6
- Pages
- 970-981.e8
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2902679159
- Cited by
- 69
- References
- 14
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.